HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Zinkbromid
ZnBr2 · ZnBr · Zinc bromide anhydrous · ZINC(II) BROMIDE · Zinc Bromide Powder · Zinc bromide (ZnBr2) · Zinc bromide hydrate · Zinc broMid

Identifikatoren & physikalische Daten
| CAS No. | 7699-45-8 |
|---|---|
| Summenformel | Br2Zn |
| Durchschnittliche Molmasse | 225,2 g/mol |
| SMILES | [Br][Zn][Br] |
| InChIKey | VNDYJBBGRKZCSX-UHFFFAOYSA-L |
| PubChem CID | 24375 |
| Lokaler Name | Zinkbromid |
Chemische & physikalische Eigenschaften
| Polarare Oberfläche (TPSA) | 0 |
|---|---|
| H-Brücken-Donoren | 0 |
| H-Brücken-Akzeptoren | 0 |
| Frei drehbare Bindungen | 0 |
| Schwere Atome | 3 |
| Formalladung | 0 |
| Komplexität | 2,8 |
| Schmelzpunkt | 394 °C (lit.) |
| Siedepunkt | ~670 °C/1 atm (lit.) |
| Dichte | 4.22 |
| Brechungsindex | 1.5452 |
| Flammpunkt | 650°C |
| Lagerbedingungen | Store below +30°C. |
| Löslichkeit | Soluble in alcohol, ether, acetone and tetrahydrofuran.soluble, 447 g/100 mL (20 ºC) |
| Aggregatzustand | beads |
| Farbe | White to pale cream |
| Wichte | 4.2012 |
| pH | 4 (H2O, 20℃)(saturated solution) |
| Merck | 14,1029 |
| Stabilität | Stable. Forms explosive mixtures with sodium and potassium. Protect from moisture. |
| Hauptanwendungen | electroplatingmaterial synthesis precursor |
| InChI | 1S/2BrH.Zn/h2*1H/q+2/p-2 |
| InChIKey | VNDYJBBGRKZCSX-UHFFFAOYSA-L |
| SMILES | Br[Zn]Br |
| CAS Datenbank | 7699-45-8(CAS DataBase Reference) |
| NIST chemische Informationen | Zinc dibromide(7699-45-8) |
| EPA chemische Informationen | Zinc bromide (7699-45-8) |
Sicherheit & Vorschriften
| Minimum Risk Level | Intermediate Oral: 0.3 mg/kg/day (Zinc) (L134) Chronic Oral: 0.3 mg/kg/day (Zinc) (L134) |
|---|---|
| Treatment | EYES: irrigate opened eyes for several minutes under running water. INGESTION: do not induce vomiting. Rinse mouth with water (never give anything by mouth to an unconscious person). Seek immediate medical advice. SKIN: should be treated immediately by rinsing the affected parts in cold running water for at least 15 minutes, followed by thorough washing with soap and water. If necessary, the person should shower and change contaminated clothing and shoes, and then must seek medical attention. INHALATION: supply fresh air. If required provide artificial respiration. |
| Gesundheitliche Auswirkungen | Chronic exposure to zinc causes anemia, atazia, lethargy, and decreases the level of good cholesterol in the body. It is also believed to cause pancreatic and reproductive damage. Bromine vapour causes irritation and direct damage to the mucous membranes. Elemental bromine also burns the skin. The bromide ion is a central nervous system depressant and chronic exposure produces neuronal effects. This is called bromism and can result in central reactions reaching from somnolence to coma, cachexia, exicosis, loss of reflexes or pathologic reflexes, clonic seizures, tremor, ataxia, loss of neural sensitivity, paresis, papillar edema of the eyes, abnormal speech, cerebral edema, delirium, aggressiveness, and psychoses. (L625, L626, L627, L49) |
| Expositionspfade | Inhalation (L49)oral (L49)dermal (L49) |
| Toxizitätsübersicht | Anaemia results from the excessive absorption of zinc suppressing copper and iron absorption, most likely through competitive binding of intestinal mucosal cells. Unbalanced levels of copper and zinc binding to Cu,Zn-superoxide dismutase has been linked to amyotrophic lateral sclerosis (ALS). Stomach acid dissolves metallic zinc to give corrosive zinc chloride, which can cause damage to the stomach lining. Metal fume fever is thought to be an immune response to inhaled zinc. Bromine is a powerful oxidizing agent and is able to release oxygen free radicals from the water in mucous membranes. These free radicals are also potent oxidizers and produce tissue damage. In additon, the formation of hydrobromic and bromic acids will result in secondary irritation. The bromide ion is also known to affect the central nervous system, causing bromism. This is believed to be a result of bromide ions substituting for chloride ions in the in actions of neurotransmitters and transport systems, thus affecting numerous synaptic processes. (L626, L627, A543, L48, L49, A49) |
| Signs and Symptoms | Ingestion of large doses of zinc causes stomach cramps, nausea, and vomiting. Acute inhalation of large amounts of zinc causes metal fume fever, which is characterized by chills, fever, headache, weakness, dryness of the nose and throat, chest pain, and coughing. Dermal contact with zinc results in skin irritation. Bromine vapour causes irritation and direct damage to the mucous membranes. Symptoms include lacrimation, rhinorrhoea, eye irritation with mucous secretions from the oropharyngeal and upper airways, coughing, dyspnoea, choking, wheezing, epistaxis, and headache. The bromide ion is a central nervous system depressant producing ataxia, slurred speech, tremor, nausea, vomiting, lethargy, dizziness, visual disturbances, unsteadiness, headaches, impaired memory and concentration, disorientation and hallucinations. This is called bromism. (L626, L627, L49) |
| Carcinogen Classification | No indication of carcinogenicity to humans (not listed by IARC). |
| F | 3-21 |
| Wassergefährdungsklasse (WGK) | 3 |
| TSCA-Inventar-Status | TSCA listed |
| UN-Transportnummer | UN 3260 8/PG 3 |
| Zollcode | 2827 59 00 |
| RTECS-Nr. | ZH1150000 |
| R-Sätze (R) | 34-50/53-50-51/53-43-22 |
| Gefahrensymbole | C,N |
| Sicherheitshinweise (S) | 26-36/37/39-45-60-61-29 |
| Gefahrenklasse | 8Acute Tox. 4 OralAquatic Chronic 2Eye Dam. 1Skin Corr. 1BSkin Sens. 1 |
| Verpackungsgruppe | II |
| Lagerklasse | 8B - Non-combustible corrosive hazardous materials |
| Gefahrstoffdaten | 7699-45-8(Hazardous Substances Data) |
Herstellung & Synthese
synthetische
Zinc bromide is prepared by mixing barium bromide and zinc sulfate solutions. The product barium sulfate is removed by filtration and the filtrate is evaporated to obtain crystals of zinc bromide: BaBr2 + ZnSO4 → ZnBr2 + BaSO4 Zinc bromide also may be prepared by the action of zinc with hydrobromic acid followed by crystallization.